Trial NCT03287908

View at ClinicalTrials.gov 
Org. Study IDs: 20170122
Secondary IDs: 2017-001997-41

Last trial update was posted on 2023-10-12

MeSH Interventions

Dexamethasone Pomalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Relapsed/Refractory Multiple Myeloma

Stopping Reasons

business decision, not safety reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID